IMS Health Dollars

The patient needs to know if the doctor tells a remedy based on the healthy practices medical or in the attentions of the manufacturer declares Richard T. Moore, a State Senator of Massachusetts, author of a bill requiring doctors to disclose the gifts they received from pharmaceutical firms. Duplicate spending drug industry spending last year 19,000 million of dollars in advertising and promotion, more than double the 9.1 billion of dollars of ago five years, according to the consulting firm IMS Health. Almost half the free samples that doctors receive take him. The rest includes the cost of sales, gifts to doctors and advertising representatives. Drug companies say that promoters visits and talks with the doctors are indispensable to convey scientific information about how to indicate drugs last. Their advertising aimed at consumers, say, help to those suffering from undiagnosed medical problems to seek attention and people agreed to take their remedies. The issue is in the spotlight of legislators interested in lowering the rising costs of remedies paid by the assistance programmes Social (Medicaid).

Segun Peter Shumlin, a Senator Democrat of the legislature of Vermont that I sponsor the project, laboratories would be shipped in a double marketing strategy. Make that consumers want these remedies and then make it pleasing to the doctor prescribe them, he said. And this is is getting increasingly more. The new voluntary industry guidelines new allowing companies to pay doctors for services such as consulting or lectures to colleagues. In a recent example, Shire Laboratories invite a group of psychiatrists to dinner at the Omni Berkshire Place Hotel in Manhattan, April 25. The doctors received 300 dollars for their participation in that meeting of Committee Advisor (as I said the invitation) which invited them to discuss how to use the Carbatrol remedy (in the laboratory) to treat bipolar disorder. The Vermont law would give advertising this type of payments in money.

Carbatrol, a remedy against epilepsy, has not been approved by the FDA for the treatment of bipolar disorder, but doctors have the Faculty of prescribe according to its discretion. A spokeswoman for Shire, Michele Roy, said that the company had paid physicians for their professional advice on drugs. It was not a gift, he said. The fee was compensation for the time that we were awarded.

Comments are closed.